Navigation Links
The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer
Date:9/1/2010

gy and Experimental Therapeutics at City of Hope Comprehensive Cancer Center in Duarte, CA.

Gabriel Hortobagyi, MD, who attended the ODAC meeting as a consultant to Genentech, said "There is an urgent need for the FDA and the cancer community to agree upon exactly what qualifies a drug for approval." Dr. Hortobagyi is Professor of Medicine and Chairman, Department of Breast Medical Oncology, at The University of Texas M.D. Anderson Cancer Center in Houston, TX. "There would certainly be differences of opinion from the various corners as to the requisite degree of benefit," he added, but "by having this conversation we should arrive at what is commensurate with the expectations for advanced breast cancer."

"If we only accepted cancer treatments that improve survival, we would severely limit options for our patients," said Edith P. Perez, MD, Director of the Breast Cancer Program and Professor of Medicine at Mayo Clinic in Jacksonville, FL.

A decision by FDA on bevacizumab's breast cancer indication is expected later this year.

About The ASCO Post

The ASCO Post is a newspaper intended for everyone with an interest in oncology. The ASCO Post serves a broad audience of oncology professionals and covers a wide scope of topics, including clinical cancer research, policy developments, and oncology practice issues. As a benefit of membership, the print edition is distributed to all U.S. ASCO members.  U.S. and international ASCO members also receive complimentary online access.  In addition, non-ASCO member medical oncologists, hematologists, and hematologist/oncologists in the United States will be eligible for a complimentary subscription.

About Harborside Press

Harborside Press is a medical publishing company based in Cold Spring Harbor, New York. Its leadership and management team has more than 50 years of experience in the field, including extensive success in buildin
'/>"/>

SOURCE Harborside Press
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
2. The Lancet publishes new data demonstrating superior efficacy of Victoza(R) (liraglutide [rDNA] injection) compared to Januvia(R) (sitagliptin) in the treatment of type 2 diabetes
3. BioTrends Publishes New Report Exploring Treatment Patterns for Anemia Across a Variety of Physician Specialties
4. NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses
5. BIA Publishes White Paper: ISO 9000 Role in Document Review, Emphasizes Quality Equals Defensibility
6. United States Patent and Trademark Office Publishes Stemedicas Patent Application for the Treatment of Diabetic Retinopathy
7. The Lancet Publishes Direct Comparison Study Between Liraglutide and Exenatide
8. The Lancet Publishes Two-Year Results of Abbotts Fully Bioabsorbable Drug Eluting Stent
9. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
10. Groundbreaking Paper Publishes Long Term Results of a Successful Phase I Clinical Trial Using Autologous Neural Stem Cells to Treat Parkinsons Disease
11. New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 2013  AbbVie (NYSE: ABBV ) ... clinical study called SONAR (Study Of Diabetic Nephropathy ... investigational compound atrasentan - when added to standard of ... with stage 2 to 4 chronic kidney disease ... large, multinational, double-blind, placebo-controlled clinical study that is ...
(Date:5/19/2013)... ORLANDO, Fla. , May 19, 2013 /PRNewswire/ ... power and low temperature radiofrequency (RF) energy is ... and eliminates or reduces the need for medication ... long-term assessment presented today at the Digestive Disease ... Orlando, Florida . ...
(Date:5/17/2013)... SHANGHAI , May 17, 2013 Medical ... drug nor a biological product. In light of their ... trail evaluations are much more complicated than drug trails ... only evaluates MD safety instead of evaluating both safety ... the US FDA (which is the same as the ...
Breaking Medicine Technology:AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Statistical Challenges in Medical Device Trail Evaluation 2
... Inc., a market leader in PyroCarbon orthopedic implants, announces ... than 40,000 PyroCarbon extremity joint replacements worldwide. ... of Ascension Orthopedics, pioneered efforts using PyroCarbon in the ... His collaborative efforts with the Mayo Clinic lead to ...
... Reportlinker.com announces that a new market research report ... Probiotics and Prebiotics in Clinical Nutrition ... Overall sales of clinical nutrition products are ... EU as well as rising incidence of illnesses and ...
Cached Medicine Technology:Ascension Orthopedics Reaches Milestone With Distribution of 40,000 PyroCarbon Implants 2Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 2Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 3Reportlinker Adds Probiotics and Prebiotics in Clinical Nutrition 4
(Date:5/20/2013)... (PRWEB) May 20, 2013 This summer, ... the world will make the pilgrimage to San Diego, ... annual Digital Health Summer Summit produced by ... a unique forum to showcase the latest digital health ... practices, and network with some of industry’s most brilliant ...
(Date:5/20/2013)... May 20, 2013 For more than ... waged a battle against drug and alcohol abuse around ... released its first guide to help Italian speakers reverse ... by the European Monitoring Centre for Drugs and Drug ... have used cannabis in the last year. As a ...
(Date:5/20/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... out in the late 1990s is more effective than ... contends. Teenagers who received four shots with the ... were 2 years old were significantly less likely to ... in California, compared to children who received all of ...
(Date:5/20/2013)... What is it about toothpaste that transforms the sweet ... the solution to that mysterious sensory phenomenon in ... the American Chemical Society,s award-winning Bytesize Science ... from the world,s largest scientific society, explains that the ... lauryl sulfate, or SLS for short. When you brush ...
(Date:5/20/2013)... MAYWOOD, Il. - Nearly three out of ... disorders during their pregnancies, a Loyola University Medical Center ... only minimal impacts on pregnant women,s quality of life, ... Scott Graziano, MD and Payton Johnson was presented during ... Clinical Meeting in New Orleans. , One hundred and ...
Breaking Medicine News(10 mins):Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2Health News:Study: Older Whooping Cough Vaccine More Effective 2Health News:Study: Older Whooping Cough Vaccine More Effective 3Health News:72 percent of pregnant women experience constipation and other bowel problems 2
... FRANCISCO -- Researchers report positive results from a Phase ... offers two modes of action. In 26 patients ... and well tolerated, including at doses yielding plasma concentrations ... chief operating officer at Thallion Pharmaceuticals in Montreal, Canada. ...
... add , WEDNESDAY, Oct. 24 (HealthDay News) -- Cigarette smoking ... a person perceives sweet-tasting foods, U.S. researchers say. , Women ... who did not smoke, according to a study in the ... Research . , The study included 27 current smokers (18 ...
... Company Becomes First to Leverage Zagat,s, Expertise to Survey ... Rate Experiences Using ... Oct. 24 WellPoint, Inc., the,nation,s largest health benefits ... of a new online survey tool that will allow,consumers ...
... is a,statement by Steven C. Anderson, IOM, CAE, President ... Stores:, The National Association of Chain Drug Stores ... sympathy, support, care and,prayer for those affected by the ... information that might be helpful to those who are ...
... Wash., Oct. 24 Verathon Medical(R), the ... the GlideScope(R) video,laryngoscope, is pleased to announce ... intellectual property right -- European Patent 1307131 ... Aircraft Medical Ltd. This,patent protects Verathon,s invention ...
... assistance for families seeking ... living and nursing homes guidance, SEATTLE, Oct. 24 ... care options, is available for free to seniors,seeking relocation options ... properties in the state of California and has,detailed information about ...
Cached Medicine News:Health News:Phase I pharmacokinetic study of ECO-4601, a novel bifunctional targeting agent 2Health News:Smoking Dulls Taste for Sweets 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 2Health News:WellPoint Taps Zagat Survey to Help Consumers Rate Experiences with Their Doctors 3Health News:State of Patient Care and Humanitarian Aid Amid the California Wild Fires 2Health News:European Patent Office Upholds Verathon's IP Against Aircraft Medical Challenge 2Health News:A Place for Mom Offers Free Assistance to California Seniors Displaced by Wildfires 2
...
Malis Curette, bayonet, titanium handle, stainless steel shaft, working distance 102 mm, length 203 mm....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Malis Needle Holders, bayonet, titanium. Working distance 2 1/2" (63 mm). Straight tip with width 0.6 mm....
Medicine Products: